Financial Services Association, September 9 (Reporter Chen Kang) This evening, 7 A-share listed companies announced that they were selected for the sixth batch of national-level specialty and new “little giant” enterprises, namely Lianhuan Pharmaceutical (600513.SH), Haomiao Technology (831856.BJ), Fuxiang Pharmaceutical (300497.SZ), Chaoda Equipment (301186.SZ), Knipp Mining (300818.SZ), China Post Technology (688648.SH), and Microchip Biotech (688321.SH).

Among them, there are two listed companies in the pharmaceutical manufacturing field. Lianhuan Pharmaceutical's main products involve several major series of urological drugs, antihistamines, cardiovascular drugs, steroidal hormone drugs, and antibiotics; Fuxiang Pharmaceutical is mainly engaged in R&D, production and sales of anti-infective drug raw materials and intermediates, and develops lithium battery electrolyte additives business and expands synthetic biological microbial protein business.

Chaoda Equipment has a strong development momentum in the field of molds and automation equipment. Its main business focuses on R&D, production and sales of molds, automobile inspection tools, automated tooling equipment and parts, and cooperates with automobile manufacturing giants such as BYD.

The core products of Naipu mining machinery are wear-resistant spare parts for mining rubber, which have many advantages such as good wear resistance, energy efficiency, and easy installation, which has effectively enhanced the development of the metal mine beneficiation industry.

Haomiao Technology is mainly engaged in the R&D, production, sales and related technical services of fire engines. The products include fire extinguishing, high-lift and special fire engines, police equipment and fire pumps, etc., which are used in national comprehensive fire rescue teams, government full-time fire brigades, and full-time fire brigades in petroleum, chemical, electricity, coal, airports, etc. The company strengthened the development of intelligent emergency products and obtained 2 new invention patents in the first half of the year.

Among the companies mentioned above, Fuxiang Pharmaceutical lost 22.46 million yuan in net profit in the first half of the year, and Haomiao Technology lost 10.34 million yuan in net profit in the first half of the year.

On September 4, the SME Information Network announced the sixth batch of specialized, special and new “little giant” enterprises, with a total of 3012 companies, including 131 A-share listed companies.

The above companies all mentioned in their announcements that successfully being selected as a national-level specialized, refined and new “little giant” enterprise is a full recognition of the company's scientific and technological innovation capabilities, specialization, refinement and characteristic development achievements, which is conducive to continuously improving the company's market competitiveness and enhancing brand awareness.